I-2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Ubunyulu ≥99.0% (HPLC) iTrelagliptin Succinate Intermediate Factory
Ubonelelo ngezoRhwebo lweTrelagliptin Succinate eziNxulumeneyo neziPhakathi:
I-6-Chloro-3-Methyluracil CAS 4318-56-3
I-2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Trelagliptin Succinate Intermediate-int D CAS 865759-24-6
I-Trelagliptin Succinate CAS 1029877-94-8
Please contact: alvin@ruifuchem.com
Igama leMchiza | I-2-Cyano-5-Flurobenzyl Bromide |
Izithethantonye | I-2-(Bromomethyl) -4-Fluorobenzonitrile |
Inombolo yeCAS | 421552-12-7 |
Inombolo yeCAT | RF-PI143 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C8H5BrFN |
Ubunzima beMolekyuli | 214.03 |
Indawo yokunyibilika | 67.0 ukuba 71.0℃ |
Inovakalelo | Ukungenwa kukufuma |
Ukunyibilika | Inyibilika kwiMethanol |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe ukuya koMthubi |
Ubunyulu / Indlela yokuHlalutya | ≥99.0% (HPLC) |
Ukufuma (KF) | ≤0.50% |
Intsalela kwi-Ignition | ≤0.30% |
Ukungacoceki Okukodwa | ≤0.50% |
Ukungcola ngokupheleleyo | ≤1.00% |
I-1 H NMR Spectrum | Ukungqinelana Nolwakhiwo |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | I-Trelagliptin Succinate (CAS: 1029877-94-8) Phakathi |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-2-Cyano-5-Flurobenzyl Bromide (CAS: 421552-12-7) enomgangatho ophezulu, esetyenziswa ngokubanzi kwi-organic synthesis, i-synthesis ye-pharmaceutical intermediates kunye nesithako esisebenzayo soxubo. (API) i-synthesis.I-2-Cyano-5-Flurobenzyl Bromide ingasetyenziswa kwi-synthesis ye-Trelagliptin Succinate (CAS: 1029877-94-8).I-Trelagliptin I-Succinate yinto ekhethiweyo, esebenza ixesha elide i-dipeptidyl peptidase-4 (DPP-4) inhibitor.I-arhente ye-antidiabetic.I-DPP-4 inhibitor esebenzayo ngomlomo evelisa ukuphuculwa kweklinikhi kunye nezibalo ezibalulekileyo kulawulo lwe-glycemic kwizigulane ezine-2 yeswekile.I-Trelagliptin Succinate yamkelwa ukuba isetyenziswe eJapan ngoMatshi ka-2015.